Immunotherapy Potential in Locally Advanced CSCC

Video

Immunotherapy Potential in Locally Advanced CSCC

A 69-Year-Old Man With Advanced CSCC

  • History and physical exam
    • An otherwise healthy, 69-year-old male, fair skinned, retired construction worker, widow
    • Presented to his PCP with what he described as a wound that was not healing behind his ear; he reported first noticing it at least 6 months ago and complained of recent onset of numbness in the area.
    • ECOG PS 1
    • The visible, ulcerated lesion was 4.5-cm in diameter and >5-mm deep
    • No palpable nodes
  • Biopsy confirmed a poorly-differentiated, infiltrative, postauricular cutaneous squamous cell carcinoma lesion with 7-mm invasion into subcutaneous fat.
  • The recommended definitive surgical approach involved partial auriculectomy; the patient declined.
  • Cemiplimab 3 mg/kg q2w was initiated
Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
Related Content